Related references
Note: Only part of the references are listed.Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice
Alessia Mastrodonato et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol
Ana Martin-Sanchez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
Cannabidiol Produces Distinct U-Shaped Dose-Response Effects on Cocaine-Induced Conditioned Place Preference and Associated Recruitment of Prelimbic Neurons in Male Rats
Hermina Nedelescu et al.
BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2022)
Emerging potential of cannabidiol in reversing proteinopathies
Raju Dash et al.
AGEING RESEARCH REVIEWS (2021)
Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: Comparison with adult rats
Cristian Bis-Humbert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Evaluating the effects of 2-BFI and tracizoline, two potent I2-imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats
Elena Hernandez-Hernandez et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice
Juan Carlos Ledesma et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Corneliu N. Stanciu et al.
PSYCHIATRIC SERVICES (2021)
Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat
Mahsa Anooshe et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
Gustavo Gonzalez-Cuevas et al.
FRONTIERS IN PHARMACOLOGY (2021)
Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
Gabriela P. Silote et al.
PHARMACEUTICALS (2021)
Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies
Sara Pisani et al.
DRUGS & AGING (2021)
Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure
Cristian Bis-Humbert et al.
PHARMACOLOGICAL REPORTS (2021)
The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake
Miguel Angel Lujan et al.
ADDICTION BIOLOGY (2020)
Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol
Cristian Bis-Humbert et al.
PSYCHOPHARMACOLOGY (2020)
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Maria S. Garcia-Gutierrez et al.
BIOMOLECULES (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Effects of cannabidiol in males and females in two different rat models of depression
Liat Shbiro et al.
PHYSIOLOGY & BEHAVIOR (2019)
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
Biological Sex Differences in Depression: A Systematic Review
Ainitze Labaka et al.
BIOLOGICAL RESEARCH FOR NURSING (2018)
Aging, inflammation and the environment
Arsun Bektas et al.
EXPERIMENTAL GERONTOLOGY (2018)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
Improved age-related deficits in cognitive performance and affective-like behavior following acute, but not repeated, 8-OH-DPAT treatments in rats: regulation of hippocampal FADD
Elena Hernandez-Hernandez et al.
NEUROBIOLOGY OF AGING (2018)
Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
Miguel Angel Lujan et al.
NEUROPHARMACOLOGY (2018)
Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test
Alonso Fernandez-Guasti et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Adolescent cocaine exposure enhances goal-tracking behavior and impairs hippocampal cell genesis selectively in adult bred low-responder rats
M. Julia Garcia-Fuster et al.
PSYCHOPHARMACOLOGY (2017)
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos et al.
FRONTIERS IN PHARMACOLOGY (2017)
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martinez-Pinilla et al.
FRONTIERS IN PHARMACOLOGY (2017)
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence
Ruben Garcia-Cabrerizo et al.
NEUROSCIENCE LETTERS (2016)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Delta(9)-tetrahydrocannabinol in Sprague-Dawley rats
Michael A. Taffe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
HIPPOCAMPAL CELL FATE REGULATION BY CHRONIC COCAINE DURING PERIODS OF ADOLESCENT VULNERABILITY: CONSEQUENCES OF COCAINE EXPOSURE DURING ADOLESCENCE ON BEHAVIORAL DESPAIR IN ADULTHOOD
R. Garcia-Cabrerizo et al.
NEUROSCIENCE (2015)
When ageing meets the blues: Are current antidepressants effective in depressed aged patients?
Daniela Felice et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
The Age-by-Disease Interaction Hypothesis of Late-Life Depression
Brandon Chad McKinney et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Using the rat forced swim test to assess antidepressant-like activity in rodents
David A. Slattery et al.
NATURE PROTOCOLS (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Decreased Proliferation of Adult Hippocampal Stem Cells During Cocaine Withdrawal: Possible Role of the Cell Fate Regulator FADD
M. Julia Garcia-Fuster et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
Bogna Ignatowska-Jankowska et al.
NEUROSCIENCE LETTERS (2011)
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
Eva M. Marco et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Impact of cocaine on adult hippocampal neurogenesis in an animal model of differential propensity to drug abuse
M. J. Garcia-Fuster et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
Yannick Marchalant et al.
NEUROBIOLOGY OF DISEASE (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Trends in antidepressant use in the older population: Results from the LASA-study over a period of 10 years
C. M. Sonnenberg et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Aging increases the susceptibility to develop anhedonia in male rats
J. J. Herrera-Perez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Ageing and neuronal vulnerability
MP Mattson et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Prevalence, correlates and recognition of depression in the oldest old: the Leiden 85-plus study
ML Stek et al.
JOURNAL OF AFFECTIVE DISORDERS (2004)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
